Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
Journal of Dermatological Science|December 12, 2018
TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in miceYan Zhou, Taylor Follansbee, Xuesong Wu, et al.
IEEE Transactions on Medical Robotics and Bionics|September 8, 2025
Serially-Connected Soft Continuum Robots for Endovascular EmergenciesAedan Mangan, Sukjun Kim, Noah Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytesAmelia Grover, Grace J Kim, Gregory Lizée, et al.
The Journal of Rheumatology|July 7, 2023
GRAPPA 2021 Pilot Grant Award ReportsFazira R Kasiem, Daisuke Yamada, Josefina Marin, et al.
AJNR. American Journal of Neuroradiology|November 18, 2017
Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ <i></i> ): A Prognostic Marker for Patients with Head and Neck Squamous Cell CarcinomasS Chawla, L A Loevner, S G Kim, et al.
The Journal of Investigative Dermatology|August 17, 2012
CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitisTomotaka Mabuchi, Tej Pratap Singh, Tomonori Takekoshi, et al.
The Journal of Investigative Dermatology|January 17, 2020
A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL)Xuesong Wu, Rajinder Singh, Daniel K Hsu, et al.
Cell Biology and Toxicology|December 19, 2025
Biosafety assessment of engineered CCL20 locked dimers in vivoDonovan Drouillard, Maria Poimenidou, Marissa Davies, et al.
Journal of Applied Microbiology|March 16, 2017
Lactococcus lactis KR-050L inhibit IL-6/STAT3 activationJ T Hwang, H-J Jang, J H Kim, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2006
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary locationTakashi Kakinuma, Hari Nadiminti, Anke S Lonsdorf, et al.
Pageof 31